MS
Therapeutic Areas
NG BIOTECH Pipeline
| Drug | Indication | Phase |
|---|---|---|
| FDA-Designated AMR Test 1 | Detection of WHO-critical drug-resistant bacterial pathogen | Breakthrough Device Designation |
| FDA-Designated AMR Test 2 | Detection of WHO-critical drug-resistant fungal/bacterial pathogen | Breakthrough Device Designation |
| Carbapenemase Resistance Detection | Antimicrobial Resistance Detection | Commercial (CE Mark) |
| ESBL Resistance Detection | Antimicrobial Resistance Detection | Commercial (CE Mark) |
| Colistin Resistance Detection | Antimicrobial Resistance Detection | Commercial (CE Mark) |
| Candida auris DETECTION | Fungal Infection Detection | Commercial (CE Mark) |